BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24626656)

  • 1. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.
    Moura Filho JP; Peixoto RL; Martins LG; Melo SD; Carvalho LL; Pereira AK; Freire EA
    An Bras Dermatol; 2014; 89(1):118-25. PubMed ID: 24626656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Skin manifestations of lupus erythematosus].
    Harr T; Bircher AJ; Häusermann P
    Ther Umsch; 2005 May; 62(5):303-12. PubMed ID: 15945221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manifestations and treatment of cutaneous lupus erythematosus (part I of II).
    Schairer D; Friedman A
    J Drugs Dermatol; 2011 Oct; 10(10):1212-4. PubMed ID: 21968677
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous manifestations of lupus erythematosus.
    Parodi A; Cozzani E
    G Ital Dermatol Venereol; 2014 Oct; 149(5):549-54. PubMed ID: 25077888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus erythematosus: Management of cutaneous manifestations during pregnancy.
    Vieitez Frade J; Filipe P
    Dermatol Ther; 2022 Jun; 35(6):e15486. PubMed ID: 35373415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
    Vale ECSD; Garcia LC
    An Bras Dermatol; 2023; 98(3):355-372. PubMed ID: 36868923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients.
    Watanabe T; Tsuchida T
    Dermatology; 1995; 190(4):277-83. PubMed ID: 7655105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.
    Vital EM; Wittmann M; Edward S; Md Yusof MY; MacIver H; Pease CT; Goodfield M; Emery P
    Arthritis Rheumatol; 2015 Jun; 67(6):1586-91. PubMed ID: 25707733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
    Patel J; Borucki R; Werth VP
    Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subacute cutaneous systemic lupus erythematosus. Presentation of two clinical cases].
    Chavarría E; Bueno C; Lázaro P; Lecona M
    Actas Dermosifiliogr; 2005 May; 96(4):248-51. PubMed ID: 16476377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dermatologic manifestations of lupus].
    Francès C
    Rev Prat; 1998 Mar; 48(6):615-9. PubMed ID: 9781131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus.
    Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; White D; Wolska H; Davis B
    Int J Dermatol; 1993 Sep; 32(9):645-51. PubMed ID: 8407091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic Lupus Erythematosus].
    Tsuchida T
    Brain Nerve; 2019 Apr; 71(4):317-321. PubMed ID: 30988213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic manifestations of systemic diseases: the example of cutaneous lupus erythematosus.
    Sepehr A; Wenson S; Tahan SR
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():112-24. PubMed ID: 20482683
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
    Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus.
    Lipsker D
    Dermatology; 2006; 212(4):324-6. PubMed ID: 16707881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.